Fate Therapeutics, Inc.

FATE ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2013

Total Assets: $55.6M

Liabilities Breakdown FY2013

Total Liabilities: $4.7M